Skip to content
Menu
INFECTIOUS ECONOMICS | by Blythe Adamson
  • Methods
    • Research
    • Course
  • Publications
    • Manuscripts
    • Abstracts
    • Other Articles
  • Teaching
  • Press
  • About
INFECTIOUS ECONOMICS | by Blythe Adamson
September 2, 2017January 24, 2018

French Innovation

During a visit to the French Ministry of Health, Emilie Sam explained to me the mechanisms for French investments in the innovation of new biomedical technologies. Many of the new life-saving products have a big impact on their budget for medicines in France.  It will be interesting to wait and see at what rate this growth continues.

 

“In 2016, 54.3% (~€65 million) of the Uncovered Innovative Procedures List allowance correspond to innovative genetic procedures which can be split into ~€36 million for oncogenetic procedures and ~€29 million for constitutional genetic procedures.”

Check out Emilie Sam’s full poster for more details.

 

 

SaveSave

SaveSave

SaveSaveSaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)

Related

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Top Posts & Pages

  • About
    About
  • Course
    Course
  • Major League Sports Lessons in COVID-19
    Major League Sports Lessons in COVID-19
  • Research
    Research
  • Manuscripts
    Manuscripts
  • CHEAT SHEET: Cancer Immunotherapy
    CHEAT SHEET: Cancer Immunotherapy
  • Causal Inference Book Club
    Causal Inference Book Club
My Tweets
Twitter
©2021 INFECTIOUS ECONOMICS | by Blythe Adamson | Powered by WordPress and Superb Themes!